Sentinel Lymph Node Surgery
As with many organ cancers in oncology, one of the most important prognostic factors in genital cancers is disease spread to lymph nodes. However, although less than 20% of gynecologic cancer cases managed by surgical treatment have lymph node involvement, surgical intervention and hospital stay are prolonged with the procedures performed to determine lymphatic involvement, and the risk of serious intraoperative complications increases, as well as long-term sequelae. Sentinel lymph node (SLN) is the first node to receive the drainage directly from a tumor. The concept of SLN is based on the thesis that the SLN status will provide information about the status of the entire lymphatic site. If there is no involvement in SLN, it should be expected that there is no disease in the remaining part of regional lymph nodes. Today, SLN study can be successfully applied in gynecology for endometrial, cervical and vulvar cancers. Surgery and hospitalization times are shortened with SLN surgery.
In addition, the patient is protected from unnecessary surgery and complications and the quality of life improves. When surgery is performed with the appropriate Robotic or Laparoscopic Systems for this procedure without the need for large abdominal incisions, the patient recovers very quickly and experiences less pain. On the other hand, the targets desired to be achieved are reached with surgical treatment.
As one of the first centers to accept SLN application in gynecologic cancer surgery, our SLN mapping and survival rate in patients with endometrial, cervical and vulvar cancer are similar to the world’s leading cancer hospitals. Our experience with sentinel lymph node surgery in gynecologic cancers has been published in internationally respected scientific journals (for details, please see ‘about me’).